- According to estimates from 14 analysts, Legend Biotech Corporation stock's average price target has fallen from $56.13 to $55.21, with forecasts ranging from $27 to $86 per share
- Based on the Jul. 1 closing price, the updated target implies approximately 85% potential upside
- Consensus rating remains at “Buy” across 16 covering analysts, with 13 Buys, 3 Holds and 0 Sells
Explore more price target data and ratings for Legend Biotech Corporation on the , and track all previous and future analyst recommendations for Legend Biotech Corporation in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.